Tivanisiran sodium ophthalmic solution

DRUG2 trials

Sponsors

Sylentis, S.A.

Conditions

Dry Eye DiseaseSjögren Syndrome

Phase 3

Tivanisiran for Dry Eye in Subjects With Sjögren's Syndrome

CompletedNCT04819269

Sylentis, S.A.Dry Eye Disease, Sjögren Syndrome

Start: 2021-05-25End: 2023-12-11Updated: 2024-02-20

Safety Study of Tivanisiran to Treat Dry Eye

CompletedNCT05310422

Sylentis, S.A.Dry Eye Disease

Start: 2022-03-24End: 2023-10-11Updated: 2026-09-09